Endocrinotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Endocrinotherapy, covering 2017-07-02 to 2017-07-02. Get the full timeline:
Most recent: Clinical Trial Update: Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer [Phase 2]